Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib

NCT01714947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Lymphoma

Interventions

DRUG: [^14C]-alisertib
DRUG: alisertib

Sponsor

Millennium Pharmaceuticals, Inc.